Loading...
|
ab96879 |
Goat polyclonal Secondary Antibody to Mouse IgG - H&L (DyLight® 488), pre-adsorbed (ab96879) |
|
ab7900 |
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate (ab7900) |
|
ab29545 |
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate (ab29545) |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Neuroscience >> Neurology process >> Neurodegenerative disease >> Parkinson's disease >> Other
Anti-PON1 antibody [17A12]
See all PON1 products (10) ...
Mouse monoclonal [17A12] to PON1
ab24261 reacts with paraoxonase1 (PON1).
ICC/IF, IHC-FoFr, ELISA, WB, Flow Cytmore details
Reacts with
Mouse, Rat, Human, Rhesus monkey
Predicted to work with
Rabbit
His tagged recombinant Human PON1 protein purified E.coli.
HeLa, HepG2 cell lysates, mouse liver tissue lysate.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.03% Sodium azide
Constituents: 0.01% BSA, 50% Glycerol, 0.87% Sodium chloride, HEPES
Concentration information loading...
IgG fraction
Monoclonal
17A12
IgG1
kappa
Cardiovascular >> Atherosclerosis >> Diabetes associated
Cell Biology >> Other Antibodies >> Oxidative Stress
Signal Transduction >> Metabolism >> Drug metabolism
Signal Transduction >> Metabolism >> Lipid metabolism
Neuroscience >> Neurology process >> Neurodegenerative disease >> Other
Cardiovascular >> Lipids / Lipoproteins >> Lipoproteins/Apolipoproteins
Cardiovascular >> Lipids / Lipoproteins >> Lipid Metabolism >> Hydrolysis
Neuroscience >> Neurology process >> Neurodegenerative disease >> Parkinson's disease >> Other
Our Abpromise guarantee covers the use of ab24261 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC/IF: Use a concentration of 1 - 5 µg/ml.
IHC-FoFr: Use at an assay dependent dilution.
ELISA: Use at an assay dependent dilution.
WB: 1/500Predicted molecular weight: 40 kDa.
Flow Cyt: Use 1µg for 106 cells.
Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
Plasma, associated with HDL (at protein level). Expressed in liver, but not in heart, brain, placenta, lung, skeletal muscle, kidney or pancreas.
Genetic variation in PON1 is associated with susceptibility to microvascular complications of diabetes type 5 (MVCD5) [MIM:612633]. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Note=Homozygosity for the Leu-54 allele is strongly associated with the development of retinal disease in diabetic patients.
Belongs to the paraoxonase family.
Glycosylated.
The signal sequence is not cleaved.
Present in two forms, form B contains a disulfide bond, form A does not.
Secreted > extracellular space.
Target information above from: UniProt accessionP27169
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - PON1 antibody [17A12] (ab24261)
All lanes : Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution
Lane 1 : HeLa cell lysates.
Lane 2 : HepG2 cell lysates.
Predicted band size : 40 kDa
Western blot

Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution + PON1 protein (ab53376) at 0.01 µg
Secondary
Goat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed (ab97040) at 1/500 dilution
developed using the ECL technique
Performed under reducing conditions.
Exposure time : 1 minute
Immunocytochemistry/ Immunofluorescence-PON1 antibody [17A12](ab24261)
](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-1.jpg)
ICC/IF image of ab24261 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab24261, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-PON1 antibody [17A12](ab24261)
](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-2.jpg)
ab24261 (1µg/ml) staining PON1 in human liver using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining of hepatocytes.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH 6.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
Flow Cytometry - PON1 antibody [17A12] (ab24261)
![Flow Cytometry - PON1 antibody [17A12] (ab24261)](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-3.jpg)
Overlay histogram showing HepG2 cells stained with ab24261 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab24261, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 100% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
This product has been referenced in:
See all 6 publications for this product
Publishing research using ab24261? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
All lanes : Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution
Lane 1 : HeLa cell lysates.
Lane 2 : HepG2 cell lysates.
Predicted band size : 40 kDa

Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution + PON1 protein (ab53376) at 0.01 µg
Secondary
Goat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed (ab97040) at 1/500 dilution
developed using the ECL technique
Performed under reducing conditions.
Exposure time : 1 minute
](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-1.jpg)
ICC/IF image of ab24261 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab24261, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-2.jpg)
ab24261 (1µg/ml) staining PON1 in human liver using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining of hepatocytes.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH 6.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
![Flow Cytometry - PON1 antibody [17A12] (ab24261)](/ps/datasheet/images/24/ab24261/PON1-Primary-antibodies-ab24261-3.jpg)
Overlay histogram showing HepG2 cells stained with ab24261 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab24261, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
